The MedTech Strategist Innovation Summit DUBLIN 2018 – Apr. 17-19 — Agenda

April 17th - 19th, 2018 The Shelbourne Hotel, Dublin — Dublin, Ireland

PLATINUM AND GOLD SPONSORS, AND MEDIA PARTNERS

Interested in Becoming a Dublin 2018 Sponsor or Media Partner?  Contact Us

 

 

A Special Thank You to Our Platinum Sponsors

Having made significant contributions to surgery for more than a century, the Johnson & Johnson Medical Devices Companies are in the business of reaching more patients and restoring more lives. The group represents the most comprehensive surgical technology and specialty solutions business in the world, offering an unparalleled breadth of products, services, programs and research and development capabilities directed at advancing patient care while delivering clinical and economic value to health care systems worldwide.

Medtronic plc, headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 88,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Seroba Life Sciences is a life sciences venture capital firm, focused on investing in breakthrough healthcare technologies that promise to improve lives and make a difference worldwide.

Headquartered in Ireland, we work with some of Europe and the world’s best entrepreneurs developing innovative medical devices, diagnostics and therapeutic drugs. We fund new healthcare opportunities through key value-adding stages, from inception through development and clinical evaluation, the generation of intellectual property, regulatory approvals and market launch and partnering with leading pharmaceutical or medtech companies.

Our team combines in-depth scientific and medical knowledge with broad regulatory and commercial expertise. We are known for patience, understanding, commitment and passion, well-demonstrated by the calibre of entrepreneurs we back, and an overriding focus on delivering improvements to people’s lives and value to our stakeholders.

Created in 1979 by the healthcare technology industry, Medmarc’s purpose is to be the superior provider of liability insurance and related risk management solutions and to support the development, testing and delivery of medical products that save lives and improve the quality of life.  Through collaboration with our parent company, ProAssurance, and our clinical trial industry experts, we provide a single source of innovative healthcare liability insurance solutions to the life sciences companies we serve.   From ideas and prototypes to the reality of commercialization and success – We can Meet Your Changing Needs.

Call me to discuss the cost of insurance coverage, what coverages are needed and when for your business plan: George Ayd (703) 652-1309.

Eugene F Collins provides a comprehensive legal service which is focused on delivering to clients commercial and pragmatic solutions to enable them to run their business more effectively and successfully. We have an expert team of people who have gained wide experience in diverse areas of law. This allows us to offer clients a specifically tailored service to deliver the commercially-focused solutions they require from a legal partner.

EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.

To support customers with changing requirements in the healthcare and pharmaceutical industries, SABIC continues to innovate with new materials and processing expertise. Our recent developments address important trends, including the need for portable technologies, the increased use of biologic drugs, the reduction of healthcare associated infections (HAIs) and the increase in regulations for medical devices and pharmaceutical products.

The surgical segment encompasses medical devices used during surgery as well as the trays designed to protect these devices during sterilization, transportation and storage. Protecting patients from infection is a critical requirement for these applications, so the materials used within this segment must withstand a wide variety of sterilization methods, or alternatively provide a cost effective alternative to metal, enabling a shift to single-use.

 

______________________________________________________________________

Gold Sponsors

CBSET Inc. is a nonprofit biomedical research institute with a mission is to advance therapeutics development through high-quality services. We collaborate with med tech and pharmaceutical sponsors with a GLP-compliant, AAALAC-accredited facility including vivaria, catheterization/imaging labs, surgical and necropsy suites, histopathology, SEM, and a range of other technologies.

As a specialized medical device CRO, genae is involved in the development and commercialization of investigational products and therapies that change medical practice. Our expertise helps you in obtaining predictable outcomes, on time, and on budget.

ICON plc is a global provider of clinical development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development. With headquarters in Dublin, Ireland, ICON currently, operates from 84 locations in 38 countries and has approximately 12,300 employees.

IMMR (previously IMM Recherche) is a Contract Research Organization specialized in preclinical surgical research. With years of experience and a cutting-edge surgical and housing facility, we are the laboratory of choice for your in vivo medical device testing.

Our main focus is on early research and development studies, Good Laboratory Practice (GLP 21 CRF part 58) compliant studies (successfully inspected by the FDA), surgical training, histopathology of explanted soft and hard tissue.

We can service your projects from the early phases of technical feasibility all the way to the final report with histopathology, requested for your regulatory submission to notified bodies.

Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler.  The firm was formed to capture the upside of investing in breakthrough life science companies during a time of unique opportunity in the space.

Members of the Lightstone team have worked together on numerous new life science enterprises over the last decade.  We have similar styles and strategies and have demonstrated success and staying power with our legacy portfolio companies through market ups and downs.  Members of the Lightstone team manage a portfolio of more than 50 medical device and biotechnology companies across the ATV and Morgenthaler legacy funds (Legacy Funds).

Olympus Medical Systems Group, a division of global technology leader Olympus, develops solutions for healthcare professionals that help improve clinical outcomes, reduce overall costs and enhance quality of life for their patients. By enabling less invasive procedures, innovative diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments, Olympus is transforming the future of healthcare.

As a Contract Research Organization in business since 1983, PMI has developed a reputation for quality science and quality service based on professional management and technical expertise. We are committed to helping customers succeed in their work, to the ethical treatment of our laboratory animals, and to furthering the commercial and humanitarian applications of the biotechnology and medical device industries.

Since its inception, PMI has established a reputation for excellent science, strong surgical and clinical skills, and customized, timely service. Built initially on word-of-mouth recommendations, our business has expanded rapidly based on our ability to respond quickly and strategically to the needs of a variety of clients, primarily medical device companies developing Class III medical devices.

Clients come to PMI for our fast, efficient and flexible approach to managing research projects. Experienced in working with both start-up and established companies, we understand the need to reach client milestones that are being monitored by the financial community. To that end, we are accustomed to expediting our review of novel protocols and accelerating our research schedule.

Applying its expertise in comparative medicine, PMI guides clients in adapting the product concept to an in vivo setting, advising on such variables as vessel size, anatomical locations and organ structure. Assistance in selecting a comparable animal model for a particular clinical indication is also provided.

PMI works hand in hand with biomedical engineers and physicians/surgeons to conduct in vivo pilot studies and fine-tune the adaptation of the prototype device, helping to optimize the product’s ease of use and clinical utility. Results can be produced quickly to help clients meet important business milestones.

Choosing the right leaders for your organization: It’s clearly a critical decision and can make the difference between unimaginable success and catastrophic failure. For nearly 30 years, Roger Brooks and his team at RBrooks Group have helped early stage and established medical device organizations find the ideal CEO, C-Suite or Board member or Vice President.

When working with RBrooks Group, clients can expect a tenacious, research-backed, goal-oriented approach to finding the best executive-level candidates often those not in the market for a job. And more importantly, Roger has an uncanny knack at convincing the right candidates that your company needs to be part of their future.

______________________________________________________________________

Media Partners

MedTech Engine is an online platform for people in medtech offering insight, resources and connections.

Brought to you by consulting services firm Medeuronet, we believe that innovation isn’t a single ‘eureka moment’ – it’s a journey of transformative thinking in strategy and practice from concept to launch. And we want to help people in medtech approach every step of this journey with insight and fresh perspective.

MedTech Engine’s online platform includes:

– Inspiring opinion from thought-leaders and perspectives from those at the forefront of innovation and entrepreneurship

– Practical resources to guide you through the MedTech Roadmap – from idea to market

– A network of connections bringing together innovators, experts, investors and established companies